Forecast, save and improve lives
Phone LinkedIn
INVESTOR RELATIONS


Please contact us anytime: This email address is being protected from spambots. You need JavaScript enabled to view it.


Predictive Neonatal Clinical Decicion Support Platform

 

Why invest in NeoPrediX?


  • Software-as-a-Service
  • Digital Health
  • Breakthrough prediction tool
  • Global market potential
  • Dedicated team of scientific and market experts
Investor Media Center



 



PRESS RELEASES


Who is NeoPrediX


NeoPrediX AG test is a Swiss company located in Basel with subsidiaries in Regensburg, Germany and Ft. Lauderdale, Florida, USA.

Contact us


Please feel free to contact us at any time for further questions and requests.
This email address is being protected from spambots. You need JavaScript enabled to view it.

NeoPrediX AG (Switzerland)
Aeschengraben 20, 4051 Basel, Switzerland
Executive Team: Jörg Schmidt, Prof. Dr. Marc Pfister , Prof. Dr. Sven Wellmann
Registered office: Basel
Commercial register number CH-270.3.016.001-3
Chairman of the board: Dr. Gerhard Ries

NeoPrediX USA, Inc. (US)
110 E Broward Blvd #1700
Fort Lauderdale, FL 33301, United States
Phone: +1 (954)-315-3884

NeoPrediX AG (Germany)
Franz-Mayer-Straße 1, 93053 Regensburg
Excecutive Board: Thorsten Waloschek (chairman), Jörg Schmidt
Registered Office: Regensburg
Commercial register number: HRB 18679
Supervisory Board: Dr. Volker Pfahlert (chairman), Arne Kirchner, Prof. Dr. Marc Pfister, Dr. Gerhard Ries, Prof. Dr. Sven Wellmann